  Inter-observer variation is a significant problem in clinical target
volume(CTV) segmentation in postoperative settings, where there is no gross
tumor present. In this scenario, the CTV is not an anatomically established
structure, but one determined by the physician based on the clinical guideline
used, the preferred tradeoff between tumor control and toxicity, their
experience and training background, and other factors. This results in high
inter-observer variability between physicians. This variability has been
considered an issue, but the absence of multiple physician CTV contours for
each patient and the significant amount of time required for dose planning have
made it impractical to study its dosimetric consequences. In this study, we
analyze the impact that variations in physician style have on dose to
organs-at-risk(OAR) by simulating the clinical workflow via deep learning. For
a given patient previously treated by one physician, we use deep learning-based
tools to simulate how other physicians would contour the CTV and how the
corresponding dose distributions would look for this patient. To simulate
multiple physician styles, we use a previously developed in-house CTV
segmentation model that can produce physician style-aware segmentations. The
corresponding dose distribution is predicted using another in-house deep
learning tool, which, can predict dose within 3% of the prescription dose, on
average, on the test data. For every test patient, four different physician
style CTVs are considered, and four different dose distributions are analyzed.
OAR dose metrics are compared, showing that even though physician style
variations result in organs getting different doses, all the important dose
metrics except Maximum Dose point are within the clinically acceptable limit.
